Integral Ad Science Holding Corp. $IAS Shares Bought by Invenomic Capital Management LP

Key Points

• Invenomic Capital Management LP has increased its stake in Integral Ad Science Holding Corp. by 84.3%, owning approximately 1.00% of the company's stock valued at $13.3 million post-acquisition.
• The company reported earnings of $0.07 per share for the latest quarter, surpassing analysts' expectations, with revenues of $149.2 million against an estimate of $143.02 million.
• Integral Ad Science's stock price has a current market cap of $1.45 billion and has seen a trading range over the past year from $6.26 to $13.62.

Invenomic Capital Management LP raised its position in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 84.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,649,983 shares of the company's stock after acquiring an additional 754,922 shares during the period. Invenomic Capital Management LP owned approximately 1.00% of Integral Ad Science worth $13,299,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Integral Ad Science by 42.7% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 155,010 shares of the company's stock worth $1,618,000 after buying an additional 46,395 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Integral Ad Science by 165.6% during the first quarter. Envestnet Asset Management Inc. now owns 84,471 shares of the company's stock worth $681,000 after buying an additional 52,664 shares during the period. Northern Trust Corp lifted its stake in shares of Integral Ad Science by 11.0% during the fourth quarter. Northern Trust Corp now owns 677,204 shares of the company's stock worth $7,070,000 after buying an additional 67,038 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Integral Ad Science by 15.9% during the first quarter. Bank of New York Mellon Corp now owns 291,079 shares of the company's stock worth $2,346,000 after buying an additional 39,988 shares during the period. Finally, ProShare Advisors LLC raised its holdings in shares of Integral Ad Science by 50.5% during the fourth quarter. ProShare Advisors LLC now owns 20,556 shares of the company's stock worth $215,000 after purchasing an additional 6,900 shares during the last quarter. 95.78% of the stock is currently owned by institutional investors and hedge funds.

Integral Ad Science Trading Down 1.8%

IAS opened at $8.74 on Friday. The firm has a market capitalization of $1.45 billion, a PE ratio of 25.71, a PEG ratio of 1.29 and a beta of 1.57. Integral Ad Science Holding Corp. has a twelve month low of $6.26 and a twelve month high of $13.62. The firm's 50-day moving average price is $8.53 and its 200 day moving average price is $8.33.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. The firm had revenue of $149.20 million for the quarter, compared to analyst estimates of $143.02 million. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

IAS has been the subject of several recent research reports. Stifel Nicolaus raised their target price on shares of Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Tuesday, July 22nd. Raymond James Financial cut their price objective on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating for the company in a report on Friday, August 8th. Wall Street Zen raised shares of Integral Ad Science from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Finally, Barclays lifted their price objective on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a report on Friday, August 8th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $13.55.

Insiders Place Their Bets

In related news, CEO Lisa Utzschneider sold 14,904 shares of the business's stock in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total transaction of $123,852.24. Following the transaction, the chief executive officer directly owned 379,316 shares in the company, valued at approximately $3,152,115.96. The trade was a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders have sold 35,073 shares of company stock worth $289,641 in the last quarter. Insiders own 2.00% of the company's stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.